Novo Nordisk | driving change to defeat serious chronic diseases
WEBNovo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Novo Nordisk Patient Assistance Program (PAP) | NovoCare®
WEBFind inspiration and motivation for staying active, eating healthy, and building up your knowledge with resources and education from NovoCare. Apply for the Novo Nordisk Patient Assistance Program (PAP) to see if you qualify to receive your Novo Nordisk diabetes medicine at no cost.
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
WEBLearn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Patient Assistance Program for People with Diabetes - NovoCare
WEBLearn about the Novo Nordisk Patient Assistance Program (PAP) for people with diabetes and find out if your patients qualify to receive medication at no cost.
Our products | Novo Nordisk U.S.
WEBNovo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
Who we Are | Novo Nordisk U.S.
WEBNovo Nordisk was named as the Best Place in the World to Work in 2022, but our people are what make our company what it is today, and will continue to shape our future. Discovering novel therapies to treat chronic disease for over 100 years. Learn who we are.
Investors - Novo Nordisk
WEBOur medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page. Helpful links. Patient help Supplier help Product list Contact us Annual Report ESG reporting Novo Nordisk Foundation. Follow us.
Latest news - Novo Nordisk
WEBAug 6, 2024 · Our scientists are currently working on novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, haemophilia, growth disorders and non-alcoholic steatohepatitis (NASH). Browse our entire R&D pipeline by study phase, or select a specific therapy areas.
Our heritage | Novo Nordisk | Driving change
WEBAddressing new unmet needs. 1970s. Both companies pursued innovation within hormone products, including oral contraceptives. In 1973, Nordisk marketed the company’s first human growth hormone, paving the way for Novo Nordisk to become one of the world’s largest manufacturers of this therapy.
What we do - Novo Nordisk
WEBNovo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in serious chronic disease treatment.